Companies » Company Overview » Glaxosmithkline Pharma Ltd.
 

Glaxosmithkline Pharma Ltd.

  • BSE: 500660
  • Sector: Health care
  • NSE: GLAXO
  • ISIN Code: INE159A01016
  • BSE

    LIVE

    15:43 | 27 Jul

  • 3383.20
  • -6.45
    (-0.19%)
  • Open
    3385.00
  • HIGH
    3389.75
  • LOW
    3363.05
  • NSE

    LIVE

    15:42 | 27 Jul

  • 3382.30
  • -6.30
    (-0.19%)
  • Open
    3388.50
  • HIGH
    3405.50
  • LOW
    3355.80
 
 
bse
15:43 PM,27th Jul 2015
3383.20
-6.45 (-0.19%)
Previous Close 3389.65
Volume 818
52-Week high 3560.00
52-Week low 2400.00
P/E 89.34
Mkt Cap.(Rs cr) 28656
Bid Price 3383.20
Bid Quantity 711.00
Offer Price 0.00
Offer Quantity 0.00
NSE
15:42 PM,27th Jul 2015

3382.30
-6.30 (-0.19%)
Bse
15:43 PM,27th Jul 2015

3383.20
-6.45 (-0.19%)
nse
15:42 PM,27th Jul 2015
3382.30
-6.30 (-0.19%)
Previous Close 3388.60
Volume 3528
52-Week high 3565.00
52-Week low 2450.00
P/E 89.34
Mkt Cap.(Rs cr) 28656
Bid Price 0.00
Bid Quantity 0.00
Offer Price 0.00
Offer Quantity 0.00

Glaxosmithkline Pharma Ltd. (GLAXO) - Company Information

GlaxoSmithKline Pharma Ltd is one of the world's leading research-based pharmaceutical and healthcare companies. The company's product portfolio includes prescription medicines and vaccines. Their prescription medicines range across therapeutic areas, such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease and respiratory diseases. They also offer a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, c... [More]

Key Fundamentals
Market Cap (Rs cr) 28,656
EPS - TTM (Rs)

[*C]

37.87
P/E Ratio (x)

[*C]

89.34
Face Value (Rs) 10
Latest Dividend (%) 625.00
Latest Dividend Date 23 Jul 2015
Dividend Yield (%) 1.85
Book Value / Share (Rs)

[*C]

215.94
P/B Ratio (x)

[*C]

15.67
[*C] Consolidated [*S] Standalone
STOCK STRENGTH
Today's Low/High
3363.05
3389.75
Week Low/High
3363.05
3450.00
Month Low/High
3210.00
3560.00
YEAR Low/High
2400.00
3560.00
All TIME Low/High
25.75
3560.00
Peer Group
Company Last Change(%)
Aurobindo Pharma 739.15 0.57
Cadila Health. 1915.00 0.02
Glenmark Pharma. 1036.65 -1.36
Glaxosmit Pharma 3383.20 -0.19
Divi's Lab. 1905.10 -2.57
Torrent Pharma. 1397.00 2.17
Wockhardt 1495.80 0.19
Returns
Period Glaxosmit Pharma Sensex NIFTY
1 Week -0.28% -3.02% -2.82%
1 Month 3.09% -0.90% -0.24%
3 Month 12.99% 1.41% 1.79%
6 Month -1.88% -6.80% -6.17%
1 Year 36.55% 5.49% 7.32%
3 Year 59.16% 63.67% 63.95%
Period Glaxosmit Pharma Sensex NIFTY
1 Week -0.40% -3.02% -2.82%
1 Month 2.88% -0.90% -0.24%
3 Month 12.89% 1.41% 1.79%
6 Month -1.83% -6.80% -6.17%
1 Year 36.26% 5.49% 7.32%
3 Year 58.75% 63.67% 63.95%
SHAREHOLDER VOTING RECOMMENDATION
Date Advisory Report
24/02 IIAS PDF Icon
Financial Results
Particulars (Rs cr) Mar 2015 Mar 2014 %Chg
Net Sales 620.31 609.85 1.72
Other Income 40.48 44.88 -9.8
Total Income 660.79 654.73 0.93
Total Expenses 500.35 502.25 -0.38
Operating Profit 160.44 152.48 5.22
Net Profit 102.85 96.54 6.54
Equity Capital 84.7 84.7 -
SHAREHOLDING PATTERN
As on Jun 2015
Research Reports
Date Broker Action Price Report
13/08 Angel Broking Neutral 2513 PDF Icon
28/04 Angel Broking Neutral 2450 PDF Icon
21/04 Centrum Sell 2492 PDF Icon
13/11 Centrum Sell 2470 PDF Icon
Company information
Chairman : D S Parekh
Vice Chairman : V Thyagarajan
Managing Director : H B Joshipura
Director : R R Bajaaj
Director : N Kaviratne
Director : P V Nayak
Executive Director (HR) : R C Sequeira
Director : D Sundaram
Company Secretary : A A Nadkarni
Director : P V Bhide
Executive Director (Technical) : Raju Krishnaswamy
Director : A N Roy
Director : Anjali P Bansal
Non Executive Director : Regis Simard
Executive Director & CFO : A Aristidou
AUDITOR: Price Waterhouse & Co
IND NAME: Pharmaceuticals - Multinational
HOUSE NAME: MNC Associate - Glaxo
Registered office
GSK House, Dr Annie Besant Road Worli,
Mumbai,Maharashtra-400030
Ph: 91-022-24959595
E-mail: ajay.a.nadhami@gsk.com
URL: http://www.gsk-india.com

Quick Links

 
Quick Links for Glaxosmithkline Pharma

Back to Top